Raymond James saw a positive improvement to its Relative Strength (RS) Rating on Monday, rising from 68 to 73.
IBD's unique RS Rating identifies market leadership by using a 1 (worst) to 99 (best) score that indicates how a stock's price performance over the trailing 52 weeks stacks up against all the other stocks in our database.
Decades of market research shows that the top-performing stocks tend to have an RS Rating north of 80 in the early stages of their moves. See if Raymond James can continue to rebound and clear that threshold.
When To Sell Stocks To Lock In Profits And Minimize Losses
Raymond James is building a flat base with a 131.19 buy point. See if it can clear the breakout price in volume at least 40% above average.
Earnings growth rose last quarter from 5% to 14%. But sales fell from 16% to 15%. Keep an eye out for the company's next round of numbers on or around Jul. 24.
The company earns the No. 5 rank among its peers in the Finance-Investment Banking/Brokers industry group. Ameriprise Financial is the top-ranked stock within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
